Press release
Postoperative Pain Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Adynxx, Cali Pharmaceuticals, Cytogel, Flexion Therapeutics, Formosa Pharmaceuticals, Grünenthal, Layerbio,
"Postoperative Pain Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Postoperative Pain Therapeutics Market.
The report provides a detailed description of the Postoperative Pain drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Postoperative Pain Clinical Trial Activities and Regulatory Developments in the domain @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Postoperative Pain therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Postoperative Pain drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Postoperative Pain treatment market.
Learn More about the Clinical and Commercial Development Activities in the Postoperative Pain Therapeutics Domain @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Postoperative Pain Therapeutics Analysis
Postoperative pain management aims not only to decline pain intensity but also to increase patient comfort and to improve postoperative outcomes. Pharmacologic therapies for pain include drugs from several drug classes. Pain-relieving analgesics include opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen. Providers also elect to manage acute pain with benzodiazepines, muscle relaxants, antidepressants, alpha-2 agonists, gamma-aminobutyric agonists, and cannabinoids. Topical agents, such as capsaicin and lidocaine, are also used.
Nonpharmacologic therapies for pain are becoming more widely used to avoid problems associated with pharmacologic therapies. Examples of nonpharmacologic therapies include acupuncture, psychological approaches (cognitive behavioral therapy, mindfulness-based stress reduction), chiropractic manipulation, physical therapy, transcutaneous electrical stimulation, massage therapy, exercise, and other complementary and alternative medicine therapies (CAM).
Current treatment for postoperative pain involves approved drugs such as Anjeso, Dextenza, Inveltys, etc., in NSAIDs and corticosteroids. Some approved opioid medications are also present in the market, such as Dsuvia approved in 2018 in both the US and the EU. Some other approved drugs that are being used in postoperative pain are Penthrox and Exparel.
Several major pharma and biotech companies are developing therapies for Postoperative Pain. Currently, Vivozon is leading the therapeutics market with its Postoperative Pain drug candidates in the most advanced stage of clinical development.
Postoperative Pain Companies in the Therapeutics Market Include:
ACADIA Pharmaceuticals, Adynxx, Apsen Farmaceutica, Arthritis Innovation Corporation, Cali Pharmaceuticals, Charleston Laboratories, Concentric Analgesics, Cytogel, Flexion Therapeutics, Formosa Pharmaceuticals, Grünenthal, Haisco Pharmaceutical Group, Hefei Cosource Pharmaceutical, Jiangsu Hengrui Medicine, Layerbio, Mati Therapeutics, McNeil Consumer Pharmaceuticals, MedinCell, Mylan, Nang Kuang Pharmaceutical, Neumentum Pharmaceuticals, NeurOp, Nevakar, Novartis, Novartis Pharmaceuticals, Oculis Pharma, PainReform, Salvat, Salvat Laboratories, Shijiazhuang Yiling Pharmaceutical, SiteOne Therapeutics, Surface Ophthalmics, Taiwan Liposome Company, Teikoku Pharma USA, Trevena, Unither Pharmaceuticals, Vertex Pharmaceuticals, Vivozon, Xgene Pharmaceutical, and others.
Emerging and Marketed Postoperative Pain Therapies Covered in the Report Include:
• ACP-044: ACADIA Pharmaceuticals
• CAM2048: Camurus
• CYT-1010: Cytogel Pharma
• DEXTENZA (dexamethasone): Ocular Therapeutix
• Qutenza: Grunenthal
• ST 2427: SiteOne Therapeutics
• SVT-15473 (clobetasol propionate ophthalmic nanoemulsion 0.05%): Salvat Laboratories
• TLC590: Taiwan Liposome Company
• VVZ-149: Vivozon
• ZYNRELEF (bupivacaine and meloxicam): Heron Therapeutics
And Many More
Get an in-depth Assessment of the Emerging Therapies and Postoperative Pain Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Postoperative Pain Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Postoperative Pain pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical
Molecule Type
Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Postoperative Pain Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Postoperative Pain Current Treatment Patterns
4. Postoperative Pain - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Postoperative Pain Late-Stage Products (Phase-III)
7. Postoperative Pain Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Postoperative Pain Discontinued Products
13. Postoperative Pain Product Profiles
14. Postoperative Pain Companies
15. Postoperative Pain Drugs
16. Dormant and Discontinued Products
17. Postoperative Pain Unmet Needs
18. Postoperative Pain Future Perspectives
19. Postoperative Pain Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Pain Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Adynxx, Cali Pharmaceuticals, Cytogel, Flexion Therapeutics, Formosa Pharmaceuticals, Grünenthal, Layerbio, here
News-ID: 3328269 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
